Ignite Creation Date:
2025-12-25 @ 4:55 AM
Ignite Modification Date:
2026-05-25 @ 8:06 PM
Study NCT ID:
NCT05312918
Status:
UNKNOWN
Last Update Posted:
2022-04-06
First Post:
2021-09-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Large Scale Transition to a Dolutegravir-based First-line ART in the South: Virological Response and Impact on HIV Drug Resistance in a Real Life Context (DoReaL Study)
Sponsor:
ANRS, Emerging Infectious Diseases
Organization: